Esperion Therapeutics
ESPR
#6659
Rank
$0.81 B
Marketcap
$3.18
Share price
0.00%
Change (1 day)
127.14%
Change (1 year)

P/S ratio for Esperion Therapeutics (ESPR)

P/S ratio as of August 2026 (TTM): 1.96

According to Esperion Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -2.66. At the end of 2026 the company had a P/S ratio of 1.68.

P/S ratio history for Esperion Therapeutics from 2013 to 2026

PS ratio at the end of each year

Year P/S ratio Change
20261.68-22.89%
20252.1861.39%
20241.35-53.75%
20232.92-51.95%
20226.0856.69%
20213.8831.08%
20202.96-73.21%
201911.1
2018N/A
2017N/A
2016N/A
2015N/A
2014N/A
2013N/A

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Pfizer
PFE
2.26 15.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
5.23 166.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
3.68 87.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
15.0 663.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
7.17 266.16%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
3.57 82.33%๐Ÿ‡บ๐Ÿ‡ธ USA